An Experimental Model to Study the in Vivo Survival of von Willebrand Factor
Authors:
- Peter J. LentingPLPeter J. Lenting
- Erik WesteinEWErik Westein
- Virginie TerraubeVTVirginie Terraube
- Anne-Sophie RibbaARAnne-Sophie Ribba
- Eric G. HuizingaEHEric G. Huizinga
- Dominique MeyerDMDominique Meyer
- Philip G. de GrootPGPhilip G. de Groot
- Cécile V. DenisCDCécile V. Denis
Open Access
- 1 March 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (13) , 12102-12109
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?Journal of Thrombosis and Haemostasis, 2003
- Mapping the Collagen-binding Site in the von Willebrand Factor-A3 DomainJournal of Biological Chemistry, 2003
- Von Willebrand disease type 1: a diagnosis in search of a diseaseBlood, 2003
- Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storageBlood, 2003
- A standard nomenclature for von Willebrand factor gene mutations and polymorphismsBest Practice & Research Clinical Haematology, 2001
- Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse modelsBlood, 2001
- BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTORAnnual Review of Biochemistry, 1998
- Biological effects of a S/D-treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand diseaseBlood Coagulation & Fibrinolysis, 1993
- Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetinEuropean Journal of Biochemistry, 1991
- Stabilization of Factor VIII in Plasma by the von Willebrand FactorJournal of Clinical Investigation, 1977